Carbidopa: Clinical Trials

10 trials of Carbidopa, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 active not recruiting, 1 recruiting, 1 suspended. 10 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 310Completed 6, Active not recruiting 2, Recruiting 1, Suspended 1
Phase 23Active not recruiting 1, Completed 1, Suspended 1

Follow Carbidopa: new trials by email Literature Review of Carbidopa trials Research Report on Carbidopa

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intestinal Levodopa + Entacapone Therapy (LecigonĀ®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease
LECIG (levodopa, carbidopa, entacapone intestinal gel), Best oral medication - PARKINSON DISEASE (Disorder)
Phase 3RecruitingUniversity Hospital Tuebingen1502025-10-272026-07-13
Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease
ABBV-951, Placebo for Levodopa/Carbidopa (LD/CD), Levodopa/Carbidopa (LD/CD) - Parkinson's Disease (PD)
Phase 3CompletedAbbVie1742020-10-192022-11-18
Effects of 5HTP on the Injured Human Spinal Cord
5-Hydroxytryptophan 100 MG, 5-Hydroxytryptophan, Carbidopa - Spinal Cord Injuries
Phase 2 / Phase 3Active not recruitingUniversity of Alberta62020-07-012026-09-16
Effects of 5HTP and LDOPA on CNS Excitability After SCI
5HTP, L-DOPA, Placebo oral tablet - Spinal Cord Injuries
Phase 2 / Phase 3SuspendedJessica M D'Amico302019-06-192022-10-17
Enhancement of Stroke Rehabilitation With Levodopa
IMP Levodopa 100mg/Carbidopa 25mg, Matching placebo - Acute Stroke, Stroke Rehabilitation
Phase 3Active not recruitingUniversity Hospital, Basel, Switzerland6102019-06-142024-10-15
A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER)
Optimized antiparkinsonian treatment, Levodopa-Carbidopa Intestinal Gel (LCIG), CADD-Legacy ambulatory infusion pump - Parkinson's Disease (PD)
Phase 3CompletedAbbVie632017-02-092020-08-18
Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon
BIA 9-1067, Entacapone, Placebo - Parkinson's Disease
Phase 3CompletedBial - Portela C S.A.6002011-03-012015-09-18
Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients.
BIA 9-1067, Placebo, Levodopa - Parkinson's Disease
Phase 3CompletedBial - Portela C S.A.4272011-03-012015-10-19
Carbidopa for the Treatment of Nausea and Vomiting in Familial Dysautonomia
Carbidopa, Placebo - Familial Dysautonomia
Phase 3CompletedNYU Langone Health122009-12-012016-03-28
Peripheral Dopamine in Postural Tachycardia Syndrome
Carbidopa, Placebo - Postural Tachycardia Syndrome, Orthostatic Intolerance
Phase 2 / Phase 3CompletedVanderbilt University322008-05-012022-01-24

Conditions studied

Parkinson Disease (5)  ·  Spinal Cord Injuries (2)  ·  Disruptive, Impulse Control, and Conduct Disorders (1)  ·  Dysautonomia, Familial (1)  ·  Ischemic Stroke (1)  ·  Orthostatic Intolerance (1)  ·  Postural Orthostatic Tachycardia Syndrome (1)  ·  Stroke (1)

Sponsors

AbbVie (2)  ·  Bial - Portela C S.A. (2)  ·  Jessica M D'Amico (1)  ·  NYU Langone Health (1)  ·  University Hospital Tuebingen (1)  ·  University Hospital, Basel, Switzerland (1)  ·  University of Alberta (1)  ·  Vanderbilt University (1)

Countries

United States (5)  ·  Portugal (2)  ·  Australia (1)  ·  Canada (1)  ·  Finland (1)  ·  Germany (1)  ·  Greece (1)  ·  Hungary (1)  ·  Italy (1)  ·  Slovakia (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Jessica D'Amico, PhD (2)  ·  Alfredo J Gamboa, MD (1)  ·  Horacio C Kaufmann, M.D. (1)  ·  Joaquim Ferreira, MD, PhD (1)  ·  Stefan Engelter, Prof. MD (1)

Results publications

PMID 26725544, PMID 28027332, PMID 34236101, PMID 36402160, PMID 38345741, PMID 40979212, PMID 40982270, PMID 41045349, PMID 41324738, PMID 41701756, PMID 42525438

NIH funding

2016 (1), 2018 (1), 2019 (1), 2025 (1)